AVAI BIO, INC. Total Assets

• AVAI BIO, INC. showed a decrease of -30.2% in Total Assets from 2024 to 2025.
• This data is from AVAI BIO, INC.'s annual report (Form 10-K), filed with the SEC on July 8, 2025.
• XBRL data for this metric is available from 2018 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2018: $2.0 thousand | Q3 2018: $44.5 thousand | Q4 2018: $46.3 thousand | Q4 2019: $166.3 thousand | Q1 2020: $420.0 thousand | Q2 2020: $491.3 thousand | Q3 2020: $816.3 thousand | Q4 2020: $634.2 thousand | Q2 2021: $872.0 thousand | Q3 2021: $697.8 thousand | Q4 2021: $427.1 thousand | Q1 2022: $454.7 thousand | Q2 2022: $388.8 thousand | Q3 2022: $338.6 thousand | Q4 2022: $284.9 thousand | Q2 2023: $274.4 thousand | Q3 2023: $265.1 thousand | Q4 2023: $291.2 thousand | Q2 2024: $244.9 thousand | Q3 2024: $181.0 thousand | Q4 2024: $174.9 thousand | Q1 2025: $224.7 thousand | Q2 2025: $145.3 thousand | Q3 2025: $231.4 thousand | Q4 2025: $172.9 thousand.
• Over the full 9 years of available data (2018 to 2025), AVAI BIO, INC.'s Total Assets has grown by 8,474.8%.
• Historical annual values: Fiscal year 2025: $224.7 thousand | Fiscal year 2024: $322.0 thousand | Fiscal year 2023: $241.5 thousand | Fiscal year 2022: $454.7 thousand | Fiscal year 2021: $816.3 thousand | Fiscal year 2020: $420.0 thousand | Fiscal year 2020: $420.0 thousand | Fiscal year 2019: $30.5 thousand | Fiscal year 2018: $2.6 thousand.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026